Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Sep;15(5):182-188.
doi: 10.1177/1757177414541710.

An audit of neonatal and infant hepatitis B immunisation and serological testing in two counties of England, 2007-12

Affiliations
Review

An audit of neonatal and infant hepatitis B immunisation and serological testing in two counties of England, 2007-12

Charles Richard Beck et al. J Infect Prev. 2014 Sep.

Abstract

We audited adherence to national hepatitis B virus (HBV) immunisation policy for neonates and infants born to HBV positive mothers in two counties of England during 2007/08 to 2011/12 (n=112 in County X, n=190 in County Y). Over the five year period, 29.9% of at risk neonates in County X and 23.5% in County Y required hepatitis B immunoglobulin (HBIG) at birth. The annual median age of HBIG administration was 0.0-0.5 days. The annual median coverage and timeliness of the first (coverage range 92.3-100.0%; age of administration range 0.0-0.0 days), second (83.8-100.0%; 32.0-42.0 days), third (81.1-100.0%; 62.0-81.0 days) and fourth dose HBV immunisations (44.4-91.9%; 378.0-443.0 days) and serological testing (8.6-81.0%; 450.0-707.0 days) were calculated. Statistically significant variation was found in the coverage of third and fourth dose immunisations in County Y, age of fourth dose immunisation in County X, and the coverage and timeliness of serological testing in both counties (p < 0.05). HBIG and the first three HBV immunisations were commonly administered according to the national schedule. Fourth dose immunisations and serological tests showed poor adherence. We advocate public health interventions to improve immunisation programme outcomes and hepatitis B surface antigen testing.

Keywords: Coverage; hepatitis; immunisation; infant; neonate; vaccination.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The authors declare that there is no conflict of interest.

Figures

Figure 1.
Figure 1.
Indications for neonatal administration of hepatitis B immunoglobulin (Public Health England, 2013)

Similar articles

References

    1. Aweis D, Brabin BJ, Beeching NJ, Bunn JE, Cooper C, Gardner K, Iriyagolle C, Hart CA. (2001) Hepatitis B prevalence and risk factors for HBsAg carriage amongst Somali households in Liverpool. Communicable Disease and Public Health 4(4): 247–52. - PubMed
    1. Craine N, Parry J, O’Toole J, D’Arcy S, Lyons M. (2009) Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service. Journal of Viral Hepatitis 16(3): 219–22. - PubMed
    1. Department of Health – Immunisation Branch. (2011) Hepatitis B antenatal screening and newborn immunisation programme: best practice guidance. Department of Health: London.
    1. Department of Health. (2012) Public health functions to be exercised by the NHS Commissioning Board. Service specification no. 1. Neonatal hepatitis B immunisation programme. Department of Health: London.
    1. Dunn J, Shukla R, Neal K. (1999) Survey of neonatal hepatitis B vaccination in Leicestershire. Communicable Disease and Public Health 2(3): 218–19. - PubMed

LinkOut - more resources